TRexBio
PrivateLast Round
Series B
Extension
Jan 27, 2026
Total Funding Raised
$219M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TRexBio is a biotechnology company that develops immunoregulatory medicines by mapping human tissue regulatory T cell behavior to disease processes to identify novel therapeutic targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRexBio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
TRexBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 27, 2026 | ||||
| Series B | Nov 13, 2024 | ||||
| Series A Extension | Mar 8, 2022 | ||||
| Series A | Jun 22, 2021 |
Key People
Founding team and executive leadership
TRexBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Series B, Series B Extension |
| Janus Henderson Group | Series B Extension |
| Agent Capital | Series B |
| Balyasny Asset Management L.P. | Series B Extension |
| SV Health Investors | Series B, Series A, Series A Extension, Series B Extension, Seed |
| Alexandria Venture Investments | Series B, Series A, Series A Extension, Series B Extension |
| Pfizer Ventures | Series B, Series A, Series A Extension, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2026
$50M Series B Extension round completed.
- Nov 13, 2024
$84M round led by Delos Capital Partners.
TRexBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TRexBio's valuation, stock price, and market status.